{"id":178217,"date":"2022-08-22T11:01:29","date_gmt":"2022-08-22T11:01:29","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=178217"},"modified":"2022-08-22T11:01:29","modified_gmt":"2022-08-22T11:01:29","slug":"nonnucleoside-analog-reverse-transcriptase-inhibitor","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/","title":{"rendered":"Nonnucleoside analog reverse transcriptase inhibitor"},"content":{"rendered":"<p>Any of a class of antiretroviral drugs used to treat patients infected with the human immunodeficiency virus. NNRTIs bind with and inhibit the activity of reverse transcriptase, an enzyme needed to transcribe viral RNA into the host cell DNA. Examples include nevirapine, delavirdine, and efavirenz.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Any of a class of antiretroviral drugs used to treat patients infected with the human immunodeficiency virus. NNRTIs bind with and inhibit the activity of reverse transcriptase, an enzyme needed to transcribe viral RNA into the host cell DNA. Examples include nevirapine, delavirdine, and efavirenz. &nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-178217","post","type-post","status-publish","format-standard","hentry","category-n"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nonnucleoside analog reverse transcriptase inhibitor - Definition of Nonnucleoside analog reverse transcriptase inhibitor<\/title>\n<meta name=\"description\" content=\"Any of a class of antiretroviral drugs used to treat patients infected with the human immunodeficiency virus. NNRTIs bind with and inhibit the activity of reverse transcriptase, an enzyme needed to transcribe viral RNA into the host cell DNA. Examples include nevirapine, delavirdine, and efavirenz.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nonnucleoside analog reverse transcriptase inhibitor - Definition of Nonnucleoside analog reverse transcriptase inhibitor\" \/>\n<meta property=\"og:description\" content=\"Any of a class of antiretroviral drugs used to treat patients infected with the human immunodeficiency virus. NNRTIs bind with and inhibit the activity of reverse transcriptase, an enzyme needed to transcribe viral RNA into the host cell DNA. Examples include nevirapine, delavirdine, and efavirenz.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-22T11:01:29+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/\",\"name\":\"Nonnucleoside analog reverse transcriptase inhibitor - Definition of Nonnucleoside analog reverse transcriptase inhibitor\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2022-08-22T11:01:29+00:00\",\"dateModified\":\"2022-08-22T11:01:29+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Any of a class of antiretroviral drugs used to treat patients infected with the human immunodeficiency virus. NNRTIs bind with and inhibit the activity of reverse transcriptase, an enzyme needed to transcribe viral RNA into the host cell DNA. Examples include nevirapine, delavirdine, and efavirenz.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nonnucleoside analog reverse transcriptase inhibitor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nonnucleoside analog reverse transcriptase inhibitor - Definition of Nonnucleoside analog reverse transcriptase inhibitor","description":"Any of a class of antiretroviral drugs used to treat patients infected with the human immunodeficiency virus. NNRTIs bind with and inhibit the activity of reverse transcriptase, an enzyme needed to transcribe viral RNA into the host cell DNA. Examples include nevirapine, delavirdine, and efavirenz.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/","og_locale":"en_US","og_type":"article","og_title":"Nonnucleoside analog reverse transcriptase inhibitor - Definition of Nonnucleoside analog reverse transcriptase inhibitor","og_description":"Any of a class of antiretroviral drugs used to treat patients infected with the human immunodeficiency virus. NNRTIs bind with and inhibit the activity of reverse transcriptase, an enzyme needed to transcribe viral RNA into the host cell DNA. Examples include nevirapine, delavirdine, and efavirenz.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/","og_site_name":"Glossary","article_published_time":"2022-08-22T11:01:29+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/","name":"Nonnucleoside analog reverse transcriptase inhibitor - Definition of Nonnucleoside analog reverse transcriptase inhibitor","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2022-08-22T11:01:29+00:00","dateModified":"2022-08-22T11:01:29+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Any of a class of antiretroviral drugs used to treat patients infected with the human immunodeficiency virus. NNRTIs bind with and inhibit the activity of reverse transcriptase, an enzyme needed to transcribe viral RNA into the host cell DNA. Examples include nevirapine, delavirdine, and efavirenz.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/nonnucleoside-analog-reverse-transcriptase-inhibitor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Nonnucleoside analog reverse transcriptase inhibitor"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/178217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=178217"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/178217\/revisions"}],"predecessor-version":[{"id":178218,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/178217\/revisions\/178218"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=178217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=178217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=178217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}